Results 201 to 210 of about 3,533,139 (338)

Left atrial intramural hematoma during radiofrequency catheter ablation for atrial fibrillation: The important role of intracardiac echocardiography

Simone Nascimento dos Santos, Lorena Melo Martins da Silva, Fabio Medeiros, André Rodrigues Zanatta, Fábio Botelho, Benhur Davi Henz   +5 more
openalex   +1 more source

Molecular characterisation of human penile carcinoma and generation of paired epithelial primary cell lines

Molecular Oncology, EarlyView.
Generation of two normal and tumour (cancerous) paired human cell lines using an established tissue culture technique and their characterisation is described. Cell lines were characterised at cellular, protein, chromosome and gene expression levels and for HPV status.
Simon Broad, Mahmood Hachim, Tom Bertin, Karolina Penderecka, Rifat Hamoudi, Saif Khan, Rui Henrique, Natalie Bergmoser, Manit Arya, Kalle Sipila, Matteo Vietri Rudan, Asif Muneer, Aamir Ahmed   +12 more
wiley   +1 more source

Laser ablation for tumor ingrowth of the bridging stent via the endoscopic ultrasound-guided hepaticogastrostomy. [PDF]

Endoscopy
Suzuki Y, Miwa H, Endo K, Oishi R, Tsuchiya H, Morimoto M, Maeda S.   +6 more
europepmc   +1 more source

Pan-Alpine glacier phenology reveals lowering albedo and increase in ablation season length

, 2022
Biagio Di Mauro, Davide Fugazza
openalex   +2 more sources

Cis‐regulatory and long noncoding RNA alterations in breast cancer – current insights, biomarker utility, and the critical need for functional validation

Molecular Oncology, EarlyView.
The noncoding region of the genome plays a key role in regulating gene expression, and mutations within these regions are capable of altering it. Researchers have identified multiple functional noncoding mutations associated with increased cancer risk in the genome of breast cancer patients.
Arnau Cuy Saqués, Aracele Martinez‐Mendez, John Crown, Alex Eustace   +3 more
wiley   +1 more source

Ablation for Atrial Fibrillation: Can We Individualise Therapy or Should One Size Fit All? [PDF]

Rev Cardiovasc Med
Spath NB, Martin R, Das M, Gonna H, Sanders P, Kadhim K.   +5 more
europepmc   +1 more source

Methylation biomarkers can distinguish pleural mesothelioma from healthy pleura and other pleural pathologies

Molecular Oncology, EarlyView.
We developed and validated a DNA methylation–based biomarker panel to distinguish pleural mesothelioma from other pleural conditions. Using the IMPRESS technology, we translated this panel into a clinically applicable assay. The resulting two classifier models demonstrated excellent performance, achieving high AUC values and strong diagnostic accuracy.
Janah Vandenhoeck, Nele De Meulenaere, Thomas Vanpoucke, Joe Ibrahim, Dieter Peeters, Suresh Krishan Yogeswaran, Wen Wen, Paul Van Schil, Jeroen M. H. Hendriks, Jo Raskin, Jan van Meerbeeck, Guy Van Camp, Ken Op de Beeck   +12 more
wiley   +1 more source

Determinants of symptom relief and quality of life improvement after atrial fibrillation ablation. [PDF]

Eur Heart J Qual Care Clin Outcomes
Mulder MJ, Kemme MJB, van Pouderoijen N, Hopman LHGA, Huntelaar MJ, Hauer HA, Tahapary GJM, van Rossum AC, Allaart CP.   +8 more
europepmc   +1 more source

Strength through diversity: how cancers thrive when clones cooperate

Molecular Oncology, EarlyView.
Intratumor heterogeneity can offer direct benefits to the tumor through cooperation between different clones. In this review, Kuiken et al. discuss existing evidence for clonal cooperativity to identify overarching principles, and highlight how novel technological developments could address remaining open questions.
Marije C. Kuiken, Maartje Witsen, Emile E. Voest, Krijn K. Dijkstra   +3 more
wiley   +1 more source

Incessant Narrow QRS Complex Tachycardia in a Patient With a Prior Ablation History. [PDF]

Ann Noninvasive Electrocardiol
Liu Y, Chen Y, Xiao X, Pu X.
europepmc   +1 more source